Weight-loss jabs could become the 'new statin' for heart treatment after US regulators approve the drug

Weight-loss jabs could become the 'new statin' for heart treatment after US regulators approve the drug

Trending 2 months ago

By Jo Macfarlane

Published: 19:37 EDT, 23 March 2024 | Updated: 19:46 EDT, 23 March 2024

Blockbuster weight-loss jab Wegovy could become 'the caller statin' aft regulators successful nan US approved it arsenic a curen for bosom disease.

It follows nan results of a awesome proceedings which recovered nan drug, known arsenic semaglutide, could slash nan consequence of a bosom onslaught aliases changeable successful group pinch obesity by astir 20 per cent.

Around 50,000 group successful nan UK who are obese aliases person astatine slightest 1 different weight-related problem – which includes bosom issues – are already eligible to get Wegovy connected nan NHS and will beryllium getting those benefits.

But thousands much pinch bosom illness who whitethorn beryllium overweight but not obese could perchance get entree to it successful early aft nan institution down nan drug, Novo Nordisk, applied to UK regulator nan Medicines and Healthcare Products Regulatory Agency (MHRA) for a akin update.

Obesity master Prof Naveed Sattar, astatine nan University of Glasgow, told The Mail connected Sunday that 'cardiologists are now starting to return superior note' of semaglutide arsenic a curen for cardiovascular disease. 

Weight-loss jab Wegovy could slash nan consequence of a bosom onslaught aliases changeable successful group pinch obesity by astir 20 per cent, a awesome proceedings found

And Professor David Strain astatine nan University of Exeter said that, pending further research, it could yet beryllium utilized for illustration statins, which are fixed to astir 8 cardinal adults successful nan UK to forestall bosom attacks and strokes.

Prof Strain said: 'Statins were initially conscionable for group pinch very precocious cholesterol, past it was group pinch consequence factors.

'Now nan grounds says it doesn't matter what your cholesterin is – you will use from a statin erstwhile you scope a definite age.

'I could spot that happening successful nan early for semaglutide.'

The supplier useful by suppressing nan appetite and boosting insulin production

The supplier – which is besides utilized to dainty type 2 glucosuria nether nan marque sanction Ozempic – useful by suppressing nan appetite and boosting nan accumulation of insulin, nan hormone that regulates humor sugar. 

But Prof Strain says mounting grounds suggests it besides has a nonstop effect connected nan bosom which is not conscionable linked to nan beneficial effect of losing weight – though precisely really it helps nan bosom is still unknown.

'I'm perfectly convinced it's not conscionable obesity simplification that has this effect,' he says. 'Weight-loss room tin origin akin weight nonaccomplishment but you don't spot nan benefits connected cardiovascular consequence arsenic quickly.'

A Novo Nordisk spokesperson said a determination by nan MHRA was expected later this year.

More
Source dailymail.co.uk
dailymail.co.uk